Arpamas Seetasith

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Topics

Major Depressive Disorder

Ankylosing Spondylitis

Top Venues

Journal of medical economics

Advances in therapy

ClinicoEconomics and outcomes research : CEOR

This page only lists publications with an associated author ORCID identifier.

Publications

Jennie H Best, Sheila R Reddy, Eunice Chang, Katalin Bognar, Marian H Tarbox, Steven E Cagas, Arpamas Seetasith
Reduced mortality, complications, and economic burden among medicare beneficiaries receiving influenza antivirals. Journal of medical economics 27 (1) (2024)
Sayantani B Sindher, Christopher M Warren, Christina E Ciaccio, Arpamas Seetasith, Yutong Liu, Sachin Gupta, Ruchi Gupta
Health care resource use and costs in patients with food allergies: a United States insurance claims database analysis. Journal of medical economics 27 (1) (2024)
Jennie H Best, Sheila R Reddy, Eunice Chang, Katalin Bognar, Marian H Tarbox, Steven E Cagas, Arpamas Seetasith
Reduced mortality, complications, and economic burden among medicare beneficiaries receiving influenza antivirals. Journal of medical economics 27 (1) (2024)
Sayantani B Sindher, Christopher M Warren, Christina E Ciaccio, Arpamas Seetasith, Yutong Liu, Sachin Gupta, Sachin Gupta
Health care resource use and costs in patients with food allergies: a United States insurance claims database analysis. Journal of medical economics (2024)
Jennie H Best, Sheila R Reddy, Eunice Chang, Katalin Bognar, Marian H Tarbox, Steven E Cagas, Arpamas Seetasith
Reduced mortality, complications, and economic burden among Medicare beneficiaries receiving influenza antivirals. Journal of medical economics (2024)
William Bruce Wong, Arpamas Seetasith, Anna Hung, Leah L Zullig
Impact of list price changes on out-of-pocket costs and adherence in four high-rebate specialty drugs. PloS one 18 (1) (2023)
William Bruce Wong, Arpamas Seetasith, Anna Hung, Leah L Zullig
Impact of list price changes on out-of-pocket costs and adherence in four high-rebate specialty drugs. PloS one 18 (1) (2023)
William Bruce Wong, Arpamas Seetasith, Anna Hung, Leah L Zullig
Impact of list price changes on out-of-pocket costs and adherence in four high-rebate specialty drugs. PloS one 18 (1) (2023)
William Bruce Wong, Arpamas Seetasith, Anna Hung, Leah L Zullig
Impact of list price changes on out-of-pocket costs and adherence in four high-rebate specialty drugs. PloS one 18 (1) (2023)
William Bruce Wong, Arpamas Seetasith, Anna Hung, Leah L Zullig
Impact of list price changes on out-of-pocket costs and adherence in four high-rebate specialty drugs. PloS one 18 (1) (2023)
David Fox, Tu My To, Arpamas Seetasith, Anisha M Patel, Susan T Iannaccone
Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis. Advances in therapy 40 (3) (2022)
David Fox, Tu My To, Arpamas Seetasith, Anisha M Patel, Susan T Iannaccone
Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis. Advances in therapy 40 (3) (2022)
David Fox, Tu My To, Arpamas Seetasith, Anisha M Patel, Susan T Iannaccone
Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis. Advances in therapy (2022)
Edward E Neuberger, Tu My To, Arpamas Seetasith, Stella M Arndorfer, Chris J Wallick
Antiviral Use and Health Care Use Among US Patients With Rheumatoid Arthritis and Influenza in Three Influenza Seasons, 2016-2019. ACR open rheumatology 4 (7) (2022)
David Fox, Tu My To, Arpamas Seetasith, Anisha M Patel, Susan T Iannaccone
Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis. Advances in therapy 40 (3) (2022)
David Fox, Tu My To, Arpamas Seetasith, Anisha M Patel, Susan T Iannaccone
Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis. Advances in therapy 40 (3) (2022)
Arpamas Seetasith, Mallik Greene, Ann Hartry, Chakkarin Burudpakdee
Real-World Economic Outcomes of Brexpiprazole and Extended-Release Quetiapine Adjunctive Use in Major Depressive Disorder. ClinicoEconomics and outcomes research : CEOR 11 (2019)
Arpamas Seetasith, William Wong, Jenny Tse, Chakkarin Burudpakdee
The impact of copay assistance on patient out-of-pocket costs and treatment rates with ALK inhibitors. Journal of medical economics 22 (5) (2019)
Arpamas Seetasith, Mallik Greene, Ann Hartry, Chakkarin Burudpakdee
Changes in healthcare resource use and costs associated with early versus delayed initiation of atypical antipsychotic adjunctive treatment in major depressive disorder. Journal of medical economics 21 (9) (2018)
Mallik Greene, Chakkarin Burudpakdee, Arpamas Seetasith, Michael Behling, Holly Krasa
Evaluation of patient support program and adherence to long-acting injectable aripiprazole for patients utilizing injection local care centers. Current medical research and opinion 35 (1) (2018)